ESC Professional Premium Access

Chronic heart failure - SGLT2i

Event: ESC Congress 2022
Topic: Chronic Heart Failure
Session type: Moderated ePosters
Date: 29 August 2022
Time: 09:15 - 09:45

Congress Session

5 presentations in this session

Cardiac sodium/hydrogen exchanger (NHE11) as a novel potential target for SGLT2i in heart failure

Speaker: Doctor I. Gimenez Escamilla (Valencia, ES)
Thumbnail

SGLT2 inhibitors in real-world patients with heart failure with preserved ejection fraction

Speaker: Doctor R. Tarantini (Pavia, IT)
Thumbnail

The comparison of composite end-points between SGLT-2 inhibitors and placebo in diabetic patients with heart failure with mildly reduced ejection fraction: a meta-analysis of the literature

Speaker: Associate Professor T. Cinar (Istanbul, TR)
Thumbnail

Safety and efficacy of SGLT2 inhibitors in diabetic and non-diabetic heart failure patients, a meta-analysis of randomized controlled trials

Speaker: Doctor A. Awad (Texas City, US)
Thumbnail

SGLT2i uptake among heart failure patients with reduced ejection fraction: ongoing prescriber hesitancy and how to address this.

Speaker: Doctor B. Soh (Limerick, IE)
Thumbnail

5 speakers from this session

Doctor Isaac Gimenez Escamilla

Medical Research Institute Hospital La Fe, Valencia (Spain)
0 follower

Doctor Roberto Tarantini

University of Pavia, Pavia (Italy)
0 follower

Associate Professor Tufan Cinar

Sultan Abdulhamid Han Training and Research Hospital, Istanbul (Turkey)
0 follower

Doctor Ahmed K Awad

University of Texas health sciences, Texas City (United States of America)
0 follower

Doctor Bing Wei Thaddeus Soh

University Hospital Limerick, Limerick (Ireland)
0 follower

This platform is supported by

logo Novo Nordisk